COMMUNIQUÉ DETAILS
MEDIA
No media uploaded.
INFO
About
IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, water testing, and dairy markets. The company offers point-of-care veterinary diagnostic products comprising instruments and consumables, such as blood and urine chemistry, hematology, quantitative immunoassay testing, and urinalysis analyzers; and rapid assays, including single-use canine and feline test kits. It also provides veterinary reference laboratory diagnostic and consulting services; diagnostic and health-monitoring products for livestock and poultry; practice management systems that include hardware, software, and services; and digital radiography systems and services. In addition, the company offers products to test water for microbiological contaminants; and products to test milk for penicillin, amoxicillin, ceftiofur and cephaphirin, and tetracycline antibiotic residues, as well as other contaminants. It also provides point-of-care analyzers and related consumables used in human medical hospitals and clinics to measure electrolytes, blood gases, acid-base balance, glucose, lactate, blood urea nitrogen, and ionized calcium, as well as to calculate other parameters, such as base excess and anion gap. The company offers consulting services to veterinarians; water tests products to government laboratories, water utilities, and private certified laboratories; livestock and poultry diagnostic products to government and private laboratories that provides testing services to cattle, swine, and poultry veterinarians and producers; and milk testing products to dairy producers and processors. IDEXX Laboratories, Inc. markets and sells its products through marketing, sales, and technical service groups, as well as independent distributors and other resellers in the Americas, Europe, the Middle East, Africa, and the Asia Pacific region. The company was founded in 1983 and is headquartered in Westbrook, Maine.
- W COMPANY SITE
- P 207-556-0300
- F 207-556-4346


SEC Filing $IDXX IDEXX Laboratories, Inc.
Naqui Ali sold 8,540 shares of Idexx Laboratories Inc /de stock, or $815,826 worth, as noted in an SEC Filing today. As reported in the filing, the transactions occurred on January 31, 2013. After the transaction, Naqui Ali's stake was reported as 14,878 shares of Idexx Laboratories Inc /de stock. In addition, Naqui Ali performed several other transactions, including using transaction codes 'M' (exercise, usually of options).